scieee Science in your language
[en] (orig)

A comprehensive study of a new versatile microchip device based liquid phase microextraction for stopped-flow and double-flow conditions

Abstract

A new geometry for a versatile microfluidic-chip device based liquid phase microextraction was developed in order to enhance the preconcentration in microfluidic chips and also to enable double-flow and stopped-flow working modes. The microchip device was combined with a HPLC procedure for the simultaneous determination of two different families as model analytes, which were parabens and non-steroidal anti-inflammatories (NSAIDs): Ethyl 4-hydroxybenzoate (Et-P), Propyl 4-hydroxybenzoate (Pr-P), Butyl 4-hydroxybenzoate (Bu-P), IsoButyl 4-hydroxybenzoate (iBu-P), salycilic acid (SAC), ketoprofen (KET), naproxen (NAX), diclofenac (DIC) and ibuprofen (IBU) in urine samples. The new miniaturized microchip proposed in this work allows not only the possibility of working in double-flow conditions, but also under stagnant conditions (stopped-flow) (SF-μLPME). The sample (pH 1.5) was delivered to the SF-μLPME at 20 μL min−1 while keeping the acceptor phase (pH 11.75) under stagnant conditions during 20 min. The highest enrichment factors (between 16 and 47) were obtained under stopped-flow conditions at 20 μL min−1 (sample flow rate) after 20 min extraction; whereas the extraction efficiencies were within the range of 27–81% for all compounds. The procedure provided very low detection limits between 0.7 and 8.5 μg L−1 with a sample volume consumption of 400 μL. Parabens and NSAIDs have successfully been extracted from urine samples with excellent clean up and recoveries over 90% for all compounds. In parallel, the new device was also tested under double flow conditions, obtaining good but lower enrichment factors (between 9 and 20) and higher extraction efficiencies (between 45 and 95) after 7 min extraction, consuming a volume sample of 140 μL. The versatile device offered very high extraction efficiencies and good enrichment factor for double flow and stopped-flow conditions, respectively. In addition, this new miniaturized SF-μLPME device significantly reduced costs compared to the existing analytical techniques for sample preparation since this microchip require few microliters of sample and reagents and it is reusable

Read accessible full text

A comprehensive study of a new versatile microchip device based liquid phase microextraction for stopped-flow and double-flow conditions

Author: Ramos Payán, María Dolores; Santigosa-Murillo, Elia; Coello, Jordi; Bello López, Miguel Ángel
Publisher: Elservier
Year: 2018
DOI: 10.1016/j.chroma.2018.04.051
Source: https://idus.us.es/bitstreams/b5615c8f-3da4-4e13-b1ba-cc87c76dd46f/download
1
A comp ehensi e s udy o a new e sa ile mic ochip de ice based liquid phase mic oex ac ion
1
o s opped- low and double- low condi ions.
2
Ma ía Ramos Payána*, Elia San igosa Mu illob, Jo di Coellob, Miguel Ángel Bello Lópeza
3
aDepa men o Analy ical Chemis y, Facul y o Chemis y, c/P o . Ga cía González s/n, 41012,
4
Se ille, Spain
5
bDepa men o Analy ical Chemis y, Uni e si a Au ónoma de Ba celona, 08193 Bella e a,
6
Ba celona, Spain
7
*co esponding au ho : [email p o ec ed] elephone numbe : +34954557172
8
Abs ac
9
A new geome y o a e sa ile mic o luidic-chip de ice based liquid phase mic oex ac ion
10
was de eloped in o de o enhance he p econcen a ion in mic o luidic chips and also o enable
11
double- low and s opped- low wo king modes. The mic ochip de ice was combined wi h a HPLC
12
p ocedu e o he simul aneous de e mina ion o wo di e en amilies as model analy es, which we e
13
pa abens and non-s e oidal an i-in lamma o ies (NSAIDs): E hyl 4-hyd oxybenzoa e (E -P), P opyl 4-
14
hyd oxybenzoa e (P -P), Bu yl 4-hyd oxybenzoa e (Bu-P), IsoBu yl 4-hyd oxybenzoa e (iBu-P),
15
salycilic acid (SAC), ke op o en (KET), nap oxen (NAX), diclo enac (DIC) and ibup o en (IBU) in
16
u ine samples. The new minia u ized mic ochip p oposed in his wo k allows no only he possibili y
17
o wo king in double- low condi ions, bu also unde s agnan condi ions (s opped- low) (SF-µLPME).
18
The sample (pH 1.5) was deli e ed o he SF-µLPME a 20 µL min-1 while keeping he accep o phase
19
(pH 11.75) unde s agnan condi ions du ing 20 minu es. The highes en ichmen ac o s (be ween 16
20
and 47) we e ob ained unde s opped- low condi ions a 20 µL min-1 (sample low a e) a e 20 min
21
ex ac ion; whe eas he ex ac ion e iciencies we e wi hin he ange o 27-81% o all compounds.
22
The p ocedu e p o ided e y low de ec ion limi s be ween 0.7 and 8.5 µg L-1 wi h a sample olume
23
consump ion o 400 µL. Pa abens and NSAIDs ha e success ully been ex ac ed om u ine samples
24
wi h excellen clean up and eco e ies o e 90 % o all compounds. In pa allel, he new de ice was
25
also es ed unde double low condi ions, ob aining good bu lowe en ichmen ac o s (be ween 9 and
26
2
20) and highe ex ac ion e iciencies (be ween 45 and 95) a e 7 min ex ac ion, consuming a olume
27
sample o 140 µL .
28
The e sa ile de ice o e ed e y high ex ac ion e iciencies and good en ichmen ac o o double
29
low and s opped- low condi ions, espec i ely. In addi ion, his new minia u ized SF-µLPME de ice
30
signi ican ly educed cos s compa ed o he exis ing analy ical echniques o sample p epa a ion since
31
his mic ochip equi e ew mic oli e s o sample and eagen s and i is eusable.
32
Keywo ds: mic oex ac ion, minia u iza ion, sample p epa a ion, mic o luidic, d ugs, u ine sample.
33
1. In oduc ion
34
Liquid Phase mic oex ac ion (LPME) is a e y well-known and popula echnique used o he
35
ex ac ion o acid and basic d ugs based on he passi e di usion o he analy es om he sample (dono
36
solu ion) in o an accep o solu ion, h ough a memb ane (which suppo an o ganic sol en in o i s
37
po ous). LPME has been applied o many di e en ields, conside ing biological, pha maceu ical,
38
en i onmen al, ood, oxicology analysis, among o he s [1–7]. The anspo phenomena based on
39
passi e di usion depends no only on he na u e o he analy es, and he op imal pa ame e s (as phase’s
40
composi ion, o ganic sol en , s i ing speed, low a e, e c), bu also on he geome y o he sys em
41
used o LPME. Ano he popula echnique based liquid phase mic oex ac ion, named
42
elec omemb ane ex ac ion (EME), has also been equen ly used since i imp o es he ex ac ion o
43
compounds in many cases due o an ex e nal elec ical ield c ea ed o bo h sides o he suppo liquid
44
memb ane [8–16]. Howe e , EME also o e s some limi a ions since i s equi emen is he use o a
45
sui able and conduc o o ganic sol en o ca ying ou he ex ac ions. Bo h echniques ha e been
46
widely used o he de e mina ion o pha maceu ical d ugs ei he in biological samples (u ine) o wa e
47
samples [17-23] due o he g ea conce n ha exis s ega ding hei con ibu ion as eme gen pollu an s
48
in he en i onmen . Also, pa abens ha e been s udied due o he conce n abou hei endoc ine
49
dis up ing po en ial [24-29]. This has equi ed he use o powe ul, as and sensi i e echniques ha
50
o e be e limi s o quan i ica ion.
51
3
Up o da e, pa abens and non-s e oidal an iin lama o ies ha en been de e mined by adi ional LPME
52
and EME p ocedu es esul ing in e y good en ichmen ac o s [1-4,17,19, 20, 30-33]. Those
53
p ocedu es allowed good en ichmen ac o s bu low ex ac ion e iciencies. In he las yea s, liquid-
54
liquid ex ac ion has been minia u ized in o mic o luidic de ices in o de o add ess he limi a ions
55
om adi ional p ocedu es and hese chip de ices a e becoming an a ac i e al e na i e due o he
56
many ad an ages ha i p esen s [34-42]. The mic ochip de ices o sample ea men ha e wo
57
channels ha allow wo king in wo di e en ways based on he low a e o each phase: double- low
58
o s opped- low condi ions. In double- low condi ions, bo h phases (sample and accep o ) a e mo ing
59
a some low a e. Howe e , in s opped- low condi ions, he accep o phase keep s agnan while he
60
sample solu ion is used a some low a e. Recen mic ochip de ices based LPME, ha e been
61
demons a ed o wo k only unde double- low condi ions bu no unde s opped- low condi ions in a
62
single s ep since he la e equi ed o collec se e al ex ac s o i s di ec injec ion in o HPLC. This
63
was due o he low sample olume a ailable in he accep o channel ( 2 µL) [41,42] and consequen ly,
64
he analysis ime inc eased and he ep oducibili y dec eased when an en ichmen ac o was necessa y
65
p io o he sample analysis. On he o he hand, he de ices did no allowed high p econcen a ion
66
ac o s al hough he sample low a e was signi ican ly inc eased unde double- low condi ions.
67
Based on he cu en limi a ions o mic o luidic de ices o mic oex ac ion p ocedu es, he aim o his
68
wo k was o de elop a new e sa ile and e ec i e mic o luidic de ice in o de o o e come he
69
limi a ions om p e ious mic o luidic de ices, inc easing he p econcen a ion and allowing wo king
70
unde s opped- low condi ions compa ible wi h di ec analysis.
71
Based on geome y aspec s, an inc ease o he dep h channel would inc ease he olume capaci y
72
con ained in he channel bu i could dec ease he anspo phenomena by passi e di usion since he
73
analy es a e a he away om he memb ane. Mic o luidic sys ems ha ollow a lamina egimen do
74
no ca y agi a ion, so di usion can be slow i he dis ance be ween he analy es and ex ac ion sol en
75
is inc eased. Mo eo e , an inc ease o he channel´s wid h would inc ease he con ac su ace be ween
76
4
he sample and he analy es, howe e , e y wide channels could des abilize he lamina low and a ec
77
he memb ane s abili y.
78
In his wo k, we p esen o he i s ime a new e sa ile and e ec i e mic o luidic chip based LPME
79
which allow he possibili y o wo king unde wo di e en wo king modes (double- low o s opped-
80
low condi ions). The mic ochip was applied o he simul aneous de e mina ion o wo di e en
81
amilies in u ine samples. This way, a comp ehensi e s udy be ween bo h di e en wo king condi ions
82
was ca ied ou . The mic ochip dec eased he sample olume and ime o analysis since no collec ing
83
samples we e needed o di ec injec ion. The p oposed s opped- low de ice (SF- µLPME) is he
84
easies mic o luidic chip o he simul aneous ex ac ions o di e en d ugs esul ing in highe
85
en ichmen ac o s wi h lowe cos ins umen a ion, simple handling, eusabili y and is s ill conside ed
86
a “g een me hod” by keeping low o ganic sol en (< 5µL) consump ion. The p oposed de ice has been
87
success ully applied o u ine samples.
88
2. Expe imen al
89
2.1. Chemicals and solu ions
90
E hyl 4-hyd oxybenzoa e (E -P), P opyl 4-hyd oxybenzoa e (P -P), Bu yl 4-hyd oxybenzoa e (Bu-P),
91
IsoBu yl 4-hyd oxybenzoa e (iBu-P), salicylic acid (SAC), ke op o en (KTP), nap oxen (NPX),
92
diclo enac (DIC), ibup o en (IBU),1-oc anol, dihexyl e he , 2-ni ophenyl oc hyl e he (NPOE),
93
o mic acid, sodium hyd oxide, chlo ide acid,sodium chlo ide and me hanol we e pu chased om
94
Fluka–Sigma–Ald ich (Mad id, Spain). 100 mg L-1 s ocks solu ions we e p epa ed in me hanol excep
95
SAC, DIC and IBU ha we e p epa ed in Milli-Q Plus wa e (Elga, pu elab op ion S-R 7-15 (Mad id,
96
Spain). All wo king dilu ions we e p epa ed using ul apu e wa e om a Milli-Q Plus by adequa e
97
dilu ions om s o ed a 4ºC. A memb ane (Celga d 2500) o 25 µm hickness, 55% po osi y, and 0.21
98
µm x 0.05 µm po es was ob ained om Celga d (Cha lo e, NC, USA).
99
2.2 Fab ica ion o he mic o luidic-chip de ice
100
5
Figu e 1 shows a scheme o he mic o luidic de ice based liquid phase mic oex ac ion. This
101
mic o luidic de ice has been e-designed and modi ied in o de o o e come he limi a ions and
102
disad an ages om p e ious mic o luidic de ices. The op imal poly(me hyl me hac yla e(PMMA)
103
de ice consis ed o wo symme ical pa e ned pla es wi h one channel o 23 mm leng h, 120 µm dep h
104
and 3 mm wid h each. Fou holes o 3 mm and 1.35 mm diame e we e d illed o assembling and
105
ixing in/ou le s Te lon ubes, espec i ely. A la polyp opylene memb ane piece o 27 mm leng h x
106
5 mm wid h sepa a ed he accep o phase (channel 1) and he dono phase (channel 2). Fi s ly, he
107
memb ane was placed o e one channel and imp egna ed wi h 4 µL o dihexyl e he . Once he
108
ex ac ing sol en was immobilized along he memb ane by capilla y o ces, he channels we e aligned
109
and he de ice was closed using ou small c ews. The inal size o a mic o luidic de ice o one single
110
ex ac ion was 47×29×6 mm, howe e by inc easing he size o bo h PMMA pla es, an a bi a ily la ge
111
numbe o ex ac ion channels can be implemen ed and independen ly add essed. Also, he mic ochip-
112
de ice can be opened any ime when exchange memb ane is needed.
113
A lase cu e (Epilog Mini 24-30 W) was used o ab ica e his chip. The bes quali y was ob ained
114
using a w i ing speed o 40%, powe o 33%, a esolu ion o 1500 and a equency o 5000.
115
Inle s Te lon ubes (accep o and dono inle s) we e connec ed o wo sepa a e mic o-sy inge pumps
116
(Ce oni GmbH, Ko bussen, Ge many). The sample (pH 1.5) was pumped in o he mic o luidic de ice
117
a 20 µLmin-1 while keeping he accep o phase (pH 11.75) cons an . The mic o luidic de ice was also
118
es ed unde double- low condi ions as desc ibed below, in o de o compa e di e en wo king modes.
119
The accep o phase was collec ed using a mic opipe e and was di ec ly injec ed in o a HPLC o
120
analysis.
121
2.3. Ch oma og aphic condi ions
122
An Agilen 1100 se ies (Ba celona, Spain) liquid ch oma og aphy equipped wi h a G1312A Bipump
123
and an au osample G1313A o 5 µL o sample injec ion was used as HPLC sys em. The column used
124
o he sepa a ion o he nine compounds was a LiCh oCART® 75-4 Pu osphe ® STAR RP-18e 3 µm
125

6
(75 mm x 4.0 mm i.d.) (VWR, Ba celona, Spain) p oceeded by a gua d column K omasil1 100 Å, C18,
126
5 µm (20 mm x 4.6 mm i.d.) (Scha lab S.L., Ba celona, Spain).
127
The mobile phase consis ed o 0.1% o mic acid (pH 2.6) (componen A) and me hanol (componen
128
B) a a low a e o 0.5 mL min-1. Sepa a ion was pe o med a 25ºC. An ini ial 60% componen B
129
was used in isoc a ic mode o 2 min, and hen a linea elu ion g adien was p og ammed om 60% o
130
80% (B) o 3.4 min and om 80 % o 86 % B o ano he 2.4 minu es. Th ee minu es we e wai ed
131
be ween injec ions which allowed e-equilib a ion o he column o he ini ial condi ions.
132
The wa eleng hs used o DAD we e 235, 255, 230, 280 and 225 nm o SAC, KTP, NAX, DIC and
133
IBU, espec i ely and 255 nm o all pa abens. The ch oma og am was comple ed in less han 10
134
minu es and he e en ion ime was 3.1, 3.3, 4.7, 5.3, 6.3, 6.6, 6.8, 8.9 and 9.1, o SAC, E -P, P -P,
135
KTP, NPX, iBu-P, Bu-P, DIC and IBU, espec i ely.
136
2.4. P epa a ion o biological samples analysis using µLPME ex ac ion
137
Spiked u ine samples we e adjus ed o pH 1.5 wi h HCl and il e ed h ough Pall Nyla loTM nylon
138
memb ane il e 0.45 µm (Pall Co po a ion, Ann A bo , Michigan, USA) p io o mic oex ac ion
139
p ocedu e.
140
2.5. Calcula ions o ex ac ion e iciency and en ichmen ac o
141
The en ichmen ac o (EFi) o he analy e i was calcula ed acco ding o he ollowing equa ion (1):
142
143
𝐸𝐹𝑖=𝐶𝑓,𝑎,𝑜𝑢𝑡𝑙𝑒𝑡
𝐶𝑖,𝑠,𝑖𝑛𝑙𝑒𝑡 (1)
144
145
whe e𝐶𝑓,𝑎,𝑜𝑢𝑡𝑙𝑒𝑡 is he concen a ion o he analy e i a he ou le o he accep o channel and 𝐶𝑖,𝑠,𝑖𝑛𝑙𝑒𝑡
146
is he ini ial concen a ion o he analy e in he sample. 𝐶𝑓,𝑎,𝑜𝑢𝑡𝑙𝑒𝑡was de e mined by HPLC UV-
147
de ec ion using ex e nal calib a ion. The en ichmen ac o is calcula ed using he same equa ion ei he
148
using double- low o s opped- low condi ions. The ex ac ion e iciency (EE) was de ined as he
149
7
ac ion o analy e ans e ed o he accep o phase om he sample. Using a double- low wo king
150
mode, he ex ac ion e iciency (EE %) was calcula ed acco ding o he ollowing equa ion (2):
151
𝐸𝐸 (%)= 𝐶𝑓,𝑎,𝑜𝑢𝑡𝑙𝑒𝑡
𝐶𝑖,𝑠,𝑖𝑛𝑙𝑒𝑡 𝑥 𝑣𝑎
𝑣𝑠 𝑥 100= 𝐸𝐹𝑖 𝑥 𝑣𝑎
𝑣𝑠 𝑥 100 (2)
152
Whe e 𝑣𝑎 𝑎𝑛𝑑 𝑣𝑠, a e he accep o and sample low a e, espec i ely.
153
Howe e , unde s opped- low condi ions, he ex ac ion e iciency (EE %) was calcula ed by
154
subs i u ing he pa ame e “accep o and sample low a e” by he “accep o and sample olume”
155
co esponding o each phase sample.
156
In o de o ob ain a global EE alue o he 9 analy es, he a e age ex ac ion e iciency index (a EEi)
157
was de ined (3):
158
𝐴𝑣𝐸𝐸𝑖=1 − √∑(𝐸𝐸𝑖−100)2
𝑛
𝑖=1 𝑛 (3)
159
160
3. Resul s and discussion
161
3.1. P inciple o he ex ac ion
162
The model analy es co esponded o wo di e en amilies: non-s e oidal an iin lama o ies and
163
pa abens. The ex ac ion o he analy es is based on a passi e di usion p ocess due o a s ong pH
164
g adien di e ence be ween he accep o and he sample solu ion. Non-s e oidal an iin lama o ies
165
con ain acid g oups wi hin a pKa ange alue o 2.5-5, while he pa aben a e es e s o
166
pa ahyd oxybenzoic acid and con ain alcohol g oup which pKa alue a e wi hin he ange o 5-8.8. A
167
h ee phases liquid phase mic oex ac ion con igu a ion p esen s wo aqueous solu ions (accep o and
168
sample) sepa a ed by he suppo liquid memb ane (o ganic sol en ). The analy es o in e es we e in
169
neu al o m in he sample solu ion and nega i ely cha ged in he accep o solu ion. This way, a pH
170
alue o unde 7 (HCl solu ion) and o e 9 (NaOH solu ion) we e used as sample and accep o solu ion,
171
espec i ely.The mic o luidic de ice was es ed using wo di e en wo king modes: double- low mode
172
and s opped- low condi ions. The memb ane was eused o consecu i e ex ac ions wi hou obse ing
173
8
memo y e ec s and he accep o phase collec ed was analyzed by HPLC once he ex ac ion was
174
comple ed. Unde s opped- low condi ions, he accep o phase was pumped con inuously o a leas
175
2-3 minu es be ween ex ac ions o clean he SLM a oiding memo y e ec s.
176
3.2. Op imiza ion o he mic ochip´s geome y
177
In LPME, he ex ac ion o he analy es depends on a anspo phenomenon based on passi e
178
di usion. The design o a new geome y was ocused on he inc easemen o he channel olume
179
capaci y (compa ible wi h di ec injec ion in o HPLC) wi hou decele a ing he anspo phenomena.
180
Di e en leng h, wide and dep h we e es ed in o de o ob ain an adequa e and s able lamina low
181
du ing he ex ac ion, conside ing a inal channel olume capaci y be ween 7 and 10 µL o i s di ec
182
analysis by HPLC a e s opped- low condi ions. The leng h was ixed a 23 mm and he wide and
183
dep h we e es ed be ween 1-3 mm and 50-300 µm, espec i ely. The dep h was he mos c i ical
184
pa ame e and i was limi ed o 120 µm since an inc eased dep h signi ican ly decele a ed he anspo
185
phenomena. In one hand, a less deep channel kep high ex ac ion e iciencies unde double- low
186
condi ions (o e 90%) bu he channel olume capaci y was no enough o wo king unde s opped-
187
low condi ions. On he o he hand, a dep h o e 150 µm dec eased he ex ac ion e iciency unde
188
double- low condi ions (less han 70%) and he en ichmen ac o dec eased 20 % o all compounds
189
unde s opped- low condi ions. Addi ionally, a wide o 2 mm equi ed a deepe channel in o de o
190
inc ease he olume capaci y and i dec eased he ex ac ion e iciencies and a wide o 4 mm did no
191
o e good ep oducibili y and s able low a e. Fo his easons, a comp omise be ween dep h, leng h
192
and wid h was ca ied ou o inc ease anspo phenomena and channel´s olume bu s ill main aining
193
minia u iza ion size and simple handling condi ions. The bes esul s and he mos ep oducible and
194
s able low we e ob ained wi h a channel geome y o 23 mm leng h, 120 µm dep h and 3 mm wid h.
195
Based on he undamen al basis o LPME, his new geome y p esen s longe and wide channels o
196
inc easing he con ac a ea be ween he analy es and he suppo liquid memb ane compa ed o
197
9
p e ious one made on PMMA. Addi ionally, he dep h was inc eased o allow a g ea e olume
198
capaci y compa ed o he only 2 µL olume capaci y om he p e ious µLPME de ice [41].
199
3.3. Op imiza ion and e alua ion o expe imen al condi ions
200
Acco ding o da a ounded in he bibliog aphy o indi idual mic oex ac ion o pa abens o non-
201
s e oidal an iin lama o ies, p elimina y expe imen s we e pe o med o de e mina e he mos sui able
202
o ganic sol en o be used as SLM o he simul aneous ex ac ion o bo h amilies. Fo he
203
op imiza ion o he o ganic sol en , a pH 3 (HCl) sample solu ion, pH 11.75 (NaOH) as accep o
204
solu ion, and 1 µL min-1 as sample and accep o low a e we e used. 2-ni ophenil oc yl e he (NPOE),
205
1-oc anol, 1-hep anol and dihexyle he we e es ed by opening he mic o luidic de ice o memb ane
206
exchange a e each o ganic sol en es . As seen in Table 1, he ex ac ion e iciency (based on 3
207
eplica e expe imen s) was e y di e en depending on he analy e. Bes a EEi was ob ained when
208
dihexyle he was used as suppo liquid memb ane, which was consequen ly used as SLM o he es
209
o he s udy.
210
Fo op imiza ion o sample and accep o composi ion, he accep o and dono phase we e es ed wi hin
211
he anges o pH 10-12 (aqueous NaOH solu ions) and 1-4 (aqueous HCl solu ions), espec i ely. The
212
dono phase, con aining 1 mg mL-1 o each analy e, was es ed keeping he accep o phase ixed a pH
213
11.75. As seen in Figu e 2, he highes peak a eas we e ob ained a pH 1.5 a e 7 minu es ex ac ion,
214
no obse ing a signi ican dec ease o he es o he pH ange es ed. Then, accep o phase
215
composi ion was op imized by keeping he sample solu ion ixed a pH 1.5 o all expe imen s. Figu e
216
3 shows ha he highes peak a eas we e ob ained a pH 12 and pH 11.75 o i e non-s e oidal
217
an iin lama o ies and ou pa abens, espec i ely. On he o he hand, pa abens we e no s able o e pH
218
12 due o a sligh deg ada ion du ing hei ex ac ion, so a comp omised pH o 11.75 was selec ed o
219
he ex ac ion o bo h amilies. A ela i e s anda d de ia ion (RSDs %) below 4 % o all analy es
220
esul ed based on 3 eplica e expe imen s o each expe imen al poin o Figu e 2 and 3. Consequen ly,
221
16
liquid memb anes. Tuning he memb ane chemis y o di e en ypes o d ug subs ances, J.
370
Ch oma og . A. 1124 (2006) 29–34.
371
[9] S. Pede sen-Bje gaa d, K.E. Rasmussen, Elec okine ic mig a ion ac oss a i icial liquid
372
memb anes: New concep o apid sample p epa a ion o biological luids, J. Ch oma og . A.
373
1109 (2006) 183–190.
374
[10] S. Pede sen-Bje gaa d, K.E. Rasmussen, Ex ac ion ac oss suppo ed liquid memb anes by use
375
o elec ical ields, Anal. Bioanal. Chem. 388 (2007) 521–523.
376
[11] S. Pede sen-Bje gaa d, K.E. Rasmussen, Elec ical po en ial can d i e liquid-liquid ex ac ion
377
o sample p epa a ion in ch oma og aphy, T AC - T ends Anal. Chem. 27 (2008) 934–941.
378
[12] T.M. Middel hon-B ue , A. Gjels ad, K.E. Rasmussen, S. Pede sen-Bje gaa d, Pa ame e s
379
a ec ing elec o memb ane ex ac ion o basic d ugs, J. Sep. Sci. 31 (2008) 753–759.
380
[13] M.D.R. Payán, B. Li, N.J. Pe e sen, H. Jensen, S.H. Hansen, S. Pede sen-Bje gaa d, Nano-
381
elec omemb ane ex ac ion, Anal. Chim. Ac a. 785 (2013) 60–66.
382
[14] M. Rezazadeh, Y. Yamini, S. Seidi, B. Eb ahimpou , Elec omemb ane su ounded solid
383
phase mic oex ac ion: A no el app oach o e icien ex ac ion om complica ed ma ices, J.
384
Ch oma og . A. 1280 (2013) 16–22.
385
[15] A. Gjels ad, H. Jensen, K.E. Rasmussen, S. Pede sen-Bje gaa d, Kine ic aspec s o hollow
386
ibe liquid-phase mic oex ac ion and elec omemb ane ex ac ion, Anal. Chim. Ac a. 742
387
(2012) 10–16.
388
[16] L.E.E. Eibak, K.E. Rasmussen, E.L. ??ies ad, S. Pede sen-Bje gaa d, A. Gjels ad, Pa allel
389
elec omemb ane ex ac ion in he 96-well o ma , Anal. Chim. Ac a. 828 (2014) 48–52.
390
[17] M. Ramos-Payán, R. Fe nández-To es, J.L. Pé ez-Be nal, M. Callejón-Mochón, M. Ángel
391
Bello-López, A no el app oach o elec omemb ane ex ac ion based on he use o sil e
392
nanome allic-deco a ed hollow ibe s, Anal. Chim. Ac a. 849 (2014) 7–11.
393
[18] K.S. Hasheminasab, A.R. Fakha i, A. Shahsa ani, H. Ahma , A new me hod o he
394

17
enhancemen o elec omemb ane ex ac ion e iciency using ca bon nano ube ein o ced
395
hollow ibe o he de e mina ion o acidic d ugs in spiked plasma, u ine, b eas milk and
396
was ewa e samples, J. Ch oma og . A. 1285 (2013) 1–6.
397
[19] S.S.H. Da a ani, A. Pou ahadi, S. Noja an, M.H. Bani aba, M. Nasi i-Aghdam, Elec o
398
memb ane ex ac ion o sodium diclo enac as an acidic compound om was ewa e , u ine,
399
bo ine milk, and plasma samples and quan i ica ion by high-pe o mance liquid
400
ch oma og aphy, Anal. Chim. Ac a. 722 (2012) 55–62.
401
[20] M. Ramos-Payán, M.Á. Bello-López, R.F. To es, M. Villa -Na a o, M. Callejón-Mochón,
402
Elec omemb ane ex ac ion (EME) and HPLC de e mina ion o non-s e oidal an i-
403
in lamma o y d ugs (NSAIDs) in was ewa e samples, Talan a. 85 (2011) 394–399.
404
[21] C. Lacey, G. McMahon, J. Bones, L. Ba on, A. Mo issey, J.M. Tobin, An LC-MS me hod o
405
he de e mina ion o pha maceu ical compounds in was ewa e ea men plan in luen and
406
e luen samples, Talan a. 75 (2008) 1089–1097.
407
[22] D.S.M. Shuk i, M.M. Sanagi, W.A.W. Ib ahim, N.N.Z. Abidin, H.Y. Aboul-Enein, Liquid
408
Ch oma og aphic De e mina ion o NSAIDs in U ine A e Dispe si e Liquid???Liquid
409
Mic oex ac ion Based on Solidi ica ion o Floa ing O ganic D ople s, Ch oma og aphia. 78
410
(2015) 987–994.
411
[23] J. Zhang, H.K. Lee, Applica ion o dynamic liquid-phase mic oex ac ion and injec ion po
412
de i a iza ion combined wi h gas ch oma og aphy-mass spec ome y o he de e mina ion o
413
acidic pha maceu ically ac i e compounds in wa e samples, J. Ch oma og . A. 1216 (2009)
414
7527–7532. doi:10.1016/j.ch oma.2009.03.051.
415
[24] D.G.J. La sson, C. de Ped o, N. Paxeus, E luen om d ug manu ac u es con ains ex emely
416
high le els o pha maceu icals, J. Haza d. Ma e . 148 (2007) 751–755.
417
[25] M.G. Soni, S.L. Taylo , N.A. G eenbe g, G.A. Bu dock, E alua ion o he heal h aspec s o
418
me hyl pa aben: a e iew o he published li e a u e, Food Chem. Toxicol. 40 (2002) 1335–
419
18
1373.
420
[26] M.G. Soni, G.A. Bu dock, S.L. Taylo , N.A. G eenbe g, Sa e y assessmen o p opyl pa aben:
421
A e iew o he published li e a u e, Food Chem. Toxicol. 39 (2001) 513–532.
422
[27] M.G. Soni, I.G. Ca abin, G.A. Bu dock, Sa e y assessmen o es e s o p-hyd oxybenzoic acid
423
(pa abens), Food Chem. Toxicol. 43 (2005) 985–1015.
424
[28] R. Golden, J. Gandy, G. Vollme . A e iew o he endoc ine ac i i y o pa abens and
425
implica ions o po en ial isk o human heal h. C i Re Toxicol. 35 (2005) 435-58.
426
[29] J.M. B ausch, G.M. Rand, A e iew o pe sonal ca e p oduc s in he aqua ic en i onmen :
427
En i onmen al concen a ions and oxici y, Chemosphe e. 82 (2011) 1518–1532.
428
[30] M. Balchen, A. Gjels ad, K.E. Rasmussen, S. Pede sen-Bje gaa d, Elec okine ic mig a ion o
429
acidic d ugs ac oss a suppo ed liquid memb ane, J. Ch oma og . A. 1152 (2007) 220–225.
430
[31] A. Es a ili, Y. Yamini, M. Ghamba ian, M. Mo adi, Analysis o pa aben p ese a i es in
431
cosme ic samples: Compa ison o h ee di e en dynamic hollow ibe liquid-phase
432
mic oex ac ion me hods, Ch oma og aphia. 77 (2014) 317–327.
433
[32] A. P ichodko, K. Jonusai e, V. Vickackai e, Hollow ib e liquid phase mic oex ac ion o
434
pa abens, Cen . Eu . J. Chem. 7 (2009) 285–290.
435
[33] M. Villa -Na a o, M. del C. Mo eno-Ca ballo, R. Fe nández-To es, M. Callejón-Mochón,
436
M.Á. Bello-López, Elec omemb ane ex ac ion o he de e mina ion o pa abens in wa e
437
samples, Anal. Bioanal. Chem. 408 (2016) 1615–1621.
438
[34] N.J. Pe e sen, J.S. Pede sen, N.N. Poulsen, H. Jensen, C. Skonbe g, S.H. Hansen, S. Pede sen-
439
Bje gaa d, On-chip elec omemb ane ex ac ion o moni o ing d ug me abolism in eal ime
440
by elec osp ay ioniza ion mass spec ome y., Analys . 137 (2012) 3321–7.
441
[35] Y. Abdossalami Asl, Y. Yamini, S. Seidi, B. Eb ahimpou , A new e ec i e on chip
442
elec omemb ane ex ac ion coupled wi h high pe o mance liquid ch oma og aphy o
443
enhancemen o ex ac ion e iciency, Anal. Chim. Ac a. 898 (2015) 42–49.
444
19
[36] B.C. Gio dano, D.S. Bu gi, S.J. Ha , A. Te ay, On-line sample p e-concen a ion in
445
mic o luidic de ices: A e iew, Anal. Chim. Ac a. 718 (2012) 11–24.
446
[37] Z.X. Cai, Q. Fang, H.W. Chen, Z.L. Fang, A mic o luidic chip based liquid-liquid ex ac ion
447
sys em wi h mic opo ous memb ane, Anal. Chim. Ac a. 556 (2006) 151–156.
448
[38] P. Wägli, Y.C. Chang, A. Homsy, L. H ozda a, H.P. He zig, N.F. De Rooij, Mic o luidic
449
d ople -based liquid-liquid ex ac ion and on-chip IR spec oscopy de ec ion o cocaine in
450
human sali a, Anal. Chem. 85 (2013) 7558–7565.
451
[39] M.D. Ramos Payán, H. Jensen, N.J. Pe e sen, S.H. Hansen, S. Pede sen-Bje gaa d, Liquid-
452
phase mic oex ac ion in a mic o luidic-chip - High en ichmen and sample clean-up om
453
small sample olumes based on h ee-phase ex ac ion, Anal. Chim. Ac a. 735 (2012) 46–53.
454
[40] B. Li, N.J. Pe e sen, M.D.R. Pay??n, S.H. Hansen, S. Pede sen-Bje gaa d, Design and
455
implemen a ion o an au oma ed liquid-phase mic oex ac ion-chip sys em coupled on-line
456
wi h high pe o mance liquid ch oma og aphy, Talan a. 120 (2014) 224–229.
457
[41] M. Ramos-Payán, S. Maspoch, A. Llobe a, An e ec i e mic o luidic based liquid-phase
458
mic oex ac ion de ice (μLPME) o ex ac ion o non-s e oidal an i-in lamma o y d ugs om
459
biological and en i onmen al samples, Anal. Chim. Ac a. 946 (2016) 56–63.
460
[42] M. Ramos-Payán, S. Maspoch, A. Llobe a, A simple and as Double-Flow mic o luidic de ice
461
based liquid-phase mic oex ac ion (DF-µLPME) o he de e mina ion o pa abens in wa e
462
samples, Talan a. 165 (2017) 496–501.
463
464
465
466
467
468
469
20
470
471
472
473
474
475
476
477
Leyend o he ables and igu es cap ions
478
Figu e 1. Schema ic o he mic ochip de ice based liquid phase mic oex ac ion
479
Figu e 2. Op imiza ion o he dono phase composi ion. SLM: dihexyle he , low a e (dono and
480
accep o phase): 1 µL min-1, accep o phase composi ion: pH 11.75
481
Figu e 3. Op imiza ion o he accep o phase composi ion. SLM: dihexyle he , low a e (dono phase):
482
1 µL min-1, low a e (accep o phase): 1 µL min-1, dono phase composi ion: pH 1.5
483
Figu e 4. Ex ac ion e iciency e sus sample low a e. SLM: dihexyle he , low a e (accep o phase):
484
1 µL min-1, dono phase composi ion: pH 11.5 and accep o phase composi ion: pH 1.5
485
Figu e 5. Ex ac ion en ichmen e sus sample phase low a e. SLM: dihexyle he , low a e (accep o
486
phase): 1 µL min-1, dono phase composi ion: pH 11.75 and accep o phase composi ion: pH 1.5
487
Figu e 6. Op imiza ion o sample solu ion low a e and ex ac ion ime o SAC, E -P, P -P, NPX,
488
KTP, iBu-P, Bu-P, DIC and IBU.
489
Figu e 7.Ch oma og am o a spiked u ine sample con aining 16 µg L-1 o all compounds excep o
490
IBU ha was 30 µg L-1. Ex ac ion ime: 20 minu es. SLM: diexyle he ; dono phase composi ion: pH
491
11.75 and accep o phase composi ion: pH 1.5. Sample low a e: 20 µL min-1. No sample dilu ion
492
Table 1. Ex ac ion e iciencies (RSD %) o he model subs ances using di e en o ganic sol en s as
493
he SLM o µLPME o acid d ugs.
494
21
Table 2. µLPME calib a ion pa ame e s, me hod de ec ion limi (MLOD), me hod quan i a ion limi
495
(MLOQ), ex ac ion e iciencies and en ichmen ac o o all analy es in a) s opped- low condi ions
496
mode a e 20 min ex ac ion and b) in double- low condi ions mode wi h an ex ac ion ime o 7 min.
497
Table 3. SF-µLPME/HPLC eco e ies (a e age o h ee de e mina ions ± s anda d de ia ion) om
498
non-dilu ed spiked u ine samples.
499
Table 4. Compa ison o igu es o me i o µLPME wi h o he analy ical echniques o de e mina ion
500
o non-s e oidal an i-in lamma o ies and pa abens.
501
502
503
504
505
506
507
508
509
510
Tables
511
Table 1
512
Table 1. Ex ac ion e iciencies (RSD %) o he model subs ances using di e en o ganic sol en s as
513
he SLM o µLPME o acid d ugs.
514
% Ex ac ion e iciency (%RSD, n=3)
NPOE
Dihexyle he
1-hep anol
1-oc anol
Salicylic acid
15 (2)
89 (1)
3 (1)
9 (1)
E hyl 4-hyd oxybenzoa e
82 (1)
100 (2)
77 (2)
85 (1)
P opyl 4-hyd oxybenzoa e
99 (1)
99 (1)
79 (1)
88 (1)
Ke op o en
94 (4)
98 (2)
12 (3)
86 (3)
Nap oxen
81 (2)
93 (2)
17 (1)
58 (2)
IsoBu yl 4-hyd oxybenzoa e
100 (2)
100 (1)
82 (2)
94 (2)
Bu yl 4-hyd oxybenzoa e
70 (2)
98 (2)
81 (3)
97 (1)
Diclo enac
54 (1)
88 (2)
10 (1)
33 (1)

22
Ibup o en
70 (2)
100 (3)
5 (2)
22 (3)
A EEi
64
94
31
51
a Sample: 1 µL min-1 o HCl a pH 3 con aining he nine d ugs each a 1 µg mL-1; accep o : 1 µL min-1 o NaOH a pH
515
11.75; ex ac ion ime: 7 min. NPOE: 2-Ni ophenyl oc yl e he
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
Table 2. µLPME calib a ion pa ame e s, me hod de ec ion limi (MLOD), me hod quan i a ion limi
533
(MLOQ), ex ac ion e iciencies and en ichmen ac o o all analy es in a) s opped- low condi ions
534
mode a e 20 min ex ac ion and b) in double- low condi ions mode wi h an ex ac ion ime o 7 min.
535
536
S ooped- low condi ions a
Double- low
condi ionsb,c
Double- low
condi ionsb,d
MLOD
(µg L-1)
MLOQ
(µg L-1)
R2
EF
EE*
EF
EE*
EF
EE*
Salicylic acid
2.0
6.7
0.9997
47
81
9
44
-
-
-
-
-
-
-
-
-
98 (1)
E hyl 4-hyd oxybenzoa e
1.1
3.7
0.9995
42
73
15
74
100 (1)
P opyl 4-hyd oxybenzoa e
0.7
2.3
0.9992
35
61
17
87
98 (1)
Ke op o en
2.9
9.7
0.9991
34
60
18
89
99 (1)
Nap oxen
1.8
6.0
0.9994
41
71
13
64
100 (1)
IsoBu yl 4-hyd oxybenzoa e
0.9
3.0
0.9990
21
44
14
70
100 (1)
Bu yl 4-hyd oxybenzoa e
1.5
5.0
0.9992
16
27
11
55
99 (1)
Diclo enac
4.2
14.0
0.9989
19
34
15
76
92 (1)
Ibup o en
8.5
28.3
0.9991
35
61
19
94
99 (1)
23
*% Ex ac ion e iciency (%RSD, n=4)
537
a Ex ac ion ime: 20 min and sample low a e 20 µL min-1
538
b Ex ac ion ime: 7 min
539
c Accep o low a e o 1 µL min-1 and sample low a e o 20 µL min-1
540
d Accep o and sample low a e o 1 µL min-1
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
Table 3. SF-µLPME/HPLC eco e ies (a e age o h ee de e mina ions ± s anda d de ia ion) om
568
non-dilu ed spiked u ine samples.
569
Spiked le el
(µg L-1)
SAC
KTP
NAX
DIC
IBU
U ine 1
7
92.5 ± 0.6
N.Q
94.4 ± 0.9
N.Q
N.D
18
94.2 ± 1.2
93.3 ± 0.8
92.4 ± 1.1
86.6 ± 0.7
89.1 ± 0.3*
50
95.5 ± 0.6
95.5 ± 0.8
98.2 ± 0.5
85.0 ± 0.5
90.2 ± 0.4
U ine 2
7
90.1 ± 0.5
N.Q
95.2 ± 0.4
N.Q
N.D
18
92.4 ± 0.8
93.4 ± 0.9
93.3 ± 0.8
86.1 ± 0.7
87.2 ± 1.5*
50
95.9 ± 1.2
94.0 ± 1.0
100.0 ± 0.8
88.8 ± 0.4
91.7 ± 0.6
*Spiked concen a ion: 30 µg L-1
570
571
572
573
574
24
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
Table 4. Compa ison o igu es o me i o µLPME wi h o he analy ical echniques o de e mina ion
590
o non-s e oidal an i-in lamma o ies and pa abens.
591
Analy ical me hod
Analy e
Ma ix
Sample
Volume
(mL)
LOQ
(µg L-1)
EF
EE %
Ex ac ion
ime (min)
Mul i-
ex ac ion
Re e ence
HF(3)-LPME-HPLC/UV
SAC, DIC,
IBU
U ine
50
41-180
70-900
-
15
No
4
HF(3)-LPME-MS/MS
SAC, DIC,
IBU
Was e
wa e
50
0.5-5
-
50-100
15
No
1
SPE-LC-MS/MS
SAC, DIC,
IBU
Was e
Wa e
500
0.1-3
-
70
> 30
No
21
DLLME-SFO-HPLC/UV
KTP, DIC
U ine
5
4-5
-
95-100
5
No
22
µLPME-HPLC/UV
double- low
SAC, KTP,
NAX, DIC,
IBU
U ine
0.007
100-500
-
75-100
5
Yes
41
HF-LPME-GCa
MeP, E P,
P P
Wa e and
u ine
8
100-300
21-154
-
40
No
32
HF-LPME-b
MeP, E P,
P P, BuP,
iP P iBuP.
BzP
Wa e
3.5
0.5
3-16
24-60
30
No
3
25
EME-HPLC/UV
E P, P P,
BuP,
iBuP. BzP
Wa e
10
2.4-5
32-49
 8
40
No
33
DF-µLPME-
HPLC/UV
double- low
E P, P P,
BuP, iBuP
Wa e
0.05
5-12
9-10
84-100
5
yes
42
DF-µLPME- HPLC/UV
(1 µL min-1)
SAC,
KTP,
NAX,
DIC, IBU
E P, P P,
BuP, iBuP
U ine
0.007
55-980
-
92-100
7
Yes
This wo k
DF-µLPME- HPLC/UV
(20 µL min-1)
SAC, KTP,
NAX, DIC,
IBU
E P, P P,
BuP, iBuP
U ine
0.14
4.5-49
9-19
44-94
7
Yes
This wo k
SF- µLPME- HPLC/UV
SAC, KTP,
NAX, DIC,
IBU
E P, P P,
BuP, iBuP
U ine
0.4
2.3-28
21-47
27-81
20
Yes
This wo k
592
a Hollow ibe liquid phase mic oex ac ion- 2 phases
593
b Hollow ibe liquid phase mic oex ac ion- 3 phases
594
595
596
597